Hypocretin (orexin) neuromodulation of stress and reward pathways

Current Opinion in Neurobiology

Volumn 29, Issue , 2014, Pages 103-108

  Giardino, William J ^a   de Lecea, Luis ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; NEUROPEPTIDE; SIGNAL PEPTIDE;

AMYGDALOID NUCLEUS; AROUSAL; BRAIN STEM; HUMAN; HYPOTHALAMUS; LATERAL HYPOTHALAMUS; LIMBIC CORTEX; NEUROMODULATION; NEUROTRANSMISSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; REWARD; STRESS; WAKEFULNESS; ARTICLE; CHRONIC STRESS; COCAINE DEPENDENCE; DEPRESSION; DRUG SEEKING BEHAVIOR; LOCUS CERULEUS; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; SIGNAL TRANSDUCTION; STRIA TERMINALIS; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM; ADAPTATION; ANIMAL; CYTOLOGY; MENTAL STRESS; METABOLISM; NERVE CELL; PATHOLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; AROUSAL; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURONS; NEUROPEPTIDES; OREXINS; REWARD; STRESS, PSYCHOLOGICAL;

EID: 84904554947     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2014.07.006     Document Type: Review

References (54)

1. Carter M.E., Borg J.S., de Lecea L. The brain hypocretins and their receptors: mediators of allostatic arousal. Curr Opin Pharmacol 2009, 9:39-45.
2. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998, 95:322-327.
3. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
4. Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005, 46:787-798.
5. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005, 25:6716-6720.
6. Adamantidis A.R., Zhang F., Aravanis A.M., Deisseroth K., de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007, 450:420-424.
7. Carter M.E., Brill J., Bonnavion P., Huguenard J.R., Huerta R., de Lecea L. Mechanism for hypocretin-mediated sleep-to-wake transitions. Proc Natl Acad Sci U S A 2012, 109:E2635-E2644.
8. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
9. Suzuki M., Beuckmann C.T., Shikata K., Ogura H., Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res 2005, 1044:116-121.
10. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 2005, 102:19168-19173.
11. Hata T., Chen J., Ebihara K., Date Y., Ishida Y., Nakahara D. Intra-ventral tegmental area or intracerebroventricular orexin-A increases the intra-cranial self-stimulation threshold via activation of the corticotropin-releasing factor system in rats. Eur J Neurosci 2011, 34:816-826.
12. Kuru M., Ueta Y., Serino R., Nakazato M., Yamamoto Y., Shibuya I., Yamashita H. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 2000, 11:1977-1980.
13. Fadel J., Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002, 111:379-387.
14. Borgland S.L., Ungless M.A., Bonci A. Convergent actions of orexin/hypocretin and CRF on dopamine neurons: emerging players in addiction. Brain Res 2010, 1314:139-144.
15. Baimel C., Borgland S.L. Hypocretin modulation of drug-induced synaptic plasticity. Prog Brain Res 2012, 198:123-131.
16. Vittoz N.M., Berridge C.W. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 2006, 31:384-395.
17. Narita M., Nagumo Y., Hashimoto S., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006, 26:398-405.
18. Boutrel B., Steiner N., Halfon O. The hypocretins and the reward function: what have we learned so far?. Front Behav Neurosci 2013, 7:59.
19. Aston-Jones G., Smith R.J., Sartor G.C., Moorman D.E., Massi L., Tahsili-Fahadan P., Richardson K.A. Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction. Brain Res 2010, 1314:74-90.
20. Baldo B.A., Daniel R.A., Berridge C.W., Kelley A.E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 2003, 464:220-237.
21. Ciriello J., Rosas-Arellano M.P., Solano-Flores L.P., de Oliveira C.V. Identification of neurons containing orexin-B (hypocretin-2) immunoreactivity in limbic structures. Brain Res 2003, 967:123-131.
22. Schmitt O., Usunoff K.G., Lazarov N.E., Itzev D.E., Eipert P., Rolfs A., Wree A. Orexinergic innervation of the extended amygdala and basal ganglia in the rat. Brain Struct Funct 2012, 217:233-256.
23. Sakamoto F., Yamada S., Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul Pept 2004, 118:183-191.
24. Johnson P.L., Samuels B.C., Fitz S.D., Federici L.M., Hammes N., Early M.C., Truitt W., Lowry C.A., Shekhar A. Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiol Behav 2012, 107:733-742.
25. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 2004, 24:11439-11448.
26. Georgescu D., Zachariou V., Barrot M., Mieda M., Willie J.T., Eisch A.J., Yanagisawa M., Nestler E.J., DiLeone R.J. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 2003, 23:3106-3111.
27. Laorden M.L., Ferenczi S., Pinter-Kubler B., Gonzalez-Martin L.L., Lasheras M.C., Kovacs K.J., Milanes M.V., Nunez C. Hypothalamic orexin-A neurons are involved in the response of the brain stress system to morphine withdrawal. PLOS ONE 2012, 7:e36871.
28. Plaza-Zabala A., Flores A., Maldonado R., Berrendero F. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal. Biol Psychiatry 2012, 71:214-223.
29. Yoshida K., McCormack S., Espana R.A., Crocker A., Scammell T.E. Afferents to the orexin neurons of the rat brain. J Comp Neurol 2006, 494:845-861.
30. Dabrowska J., Hazra R., Guo J.D., Dewitt S., Rainnie D.G. Central CRF neurons are not created equal: phenotypic differences in CRF-containing neurons of the rat paraventricular hypothalamus and the bed nucleus of the stria terminalis. Front Neurosci 2013, 7:156.
31. Conrad K.L., Davis A.R., Silberman Y., Sheffler D.J., Shields A.D., Saleh S.A., Sen N., Matthies H.J., Javitch J.A., Lindsley C.W., et al. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes. Neuropsychopharmacology 2012, 37:2253-2266.
32. Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., Bartlett S.E. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 2008, 199:109-117.
33. Lungwitz E.A., Molosh A., Johnson P.L., Harvey B.P., Dirks R.C., Dietrich A., Minick P., Shekhar A., Truitt W.A. Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiol Behav 2012, 107:726-732.
34. Avolio E., Alo R., Carelli A., Canonaco M. Amygdalar orexinergic-GABAergic interactions regulate anxiety behaviors of the Syrian golden hamster. Behav Brain Res 2011, 218:288-295.
35. Bisetti A., Cvetkovic V., Serafin M., Bayer L., Machard D., Jones B.E., Muhlethaler M. Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 2006, 142:999-1004.
36. Arendt D.H., Hassell J., Li H., Achua J.K., Guarnieri D.J., Dileone R.J., Ronan P.J., Summers C.H. Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala. Psychoneuroendocrinology 2014, 40:17-26.
37. Scott M.M., Marcus J.N., Pettersen A., Birnbaum S.G., Mochizuki T., Scammell T.E., Nestler E.J., Elmquist J.K., Lutter M. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav Brain Res 2011, 222:289-294.
38. Valentino R.J., Van Bockstaele E. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 2008, 583:194-203.
39. Inoue W., Baimoukhametova D.V., Fuzesi T., Wamsteeker Cusulin J.I., Koblinger K., Whelan P.J., Pittman Q.J., Bains J.S. Noradrenaline is a stress-associated metaplastic signal at GABA synapses. Nat Neurosci 2013, 16:605-612.
40. Flavin S.A., Winder D.G. Noradrenergic control of the bed nucleus of the stria terminalis in stress and reward. Neuropharmacology 2013, 70:324-330.
41. Sears R.M., Fink A.E., Wigestrand M.B., Farb C.R., de Lecea L., Ledoux J.E. Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus. Proc Natl Acad Sci U S A 2013, 110:20260-20265.
42. Tsai H.C., Zhang F., Adamantidis A., Stuber G.D., Bonci A., de Lecea L., Deisseroth K. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 2009, 324:1080-1084.
43. Morgan A.J., Harrod S.B., Lacy R.T., Stanley E.M., Fadel J.R. Intravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats. Drug Alcohol Depend 2013, 132:562-570.
44. Srinivasan S., Simms J.A., Nielsen C.K., Lieske S.P., Bito-Onon J.J., Yi H., Hopf F.W., Bonci A., Bartlett S.E. The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration. PLOS ONE 2012, 7:e44726.
45. Mahler S.V., Smith R.J., Aston-Jones G. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 2013, 226:687-698.
46. Mori K., Kim J., Sasaki K. Electrophysiological effects of orexin-B and dopamine on rat nucleus accumbens shell neurons in vitro. Peptides 2011, 32:246-252.
47. Patyal R., Woo E.Y., Borgland S.L. Local hypocretin-1 modulates terminal dopamine concentration in the nucleus accumbens shell. Front Behav Neurosci 2012, 6:82.
48. Qi K., Wei C., Li Y., Sui N. Orexin receptors within the nucleus accumbens shell mediate the stress but not drug priming-induced reinstatement of morphine conditioned place preference. Front Behav Neurosci 2013, 7:144.
49. Plaza-Zabala A., Flores A., Martin-Garcia E., Saravia R., Maldonado R., Berrendero F. A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior. Neuropsychopharmacology 2013, 38:1724-1736.
50. Blouin A.M., Fried I., Wilson C.L., Staba R.J., Behnke E.J., Lam H.A., Maidment N.T., Karlsson K.A.E., Lapierre J.L., Siegel J.M. Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction. Nat Commun 2013, 4:1547.
51. Ponz A., Khatami R., Poryazova R., Werth E., Boesiger P., Schwartz S., Bassetti C.L. Reduced amygdala activity during aversive conditioning in human narcolepsy. Ann Neurol 2010, 67:394-398.
52. Harris G.C., Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci 2006, 29:571-577.
53. Gonzalez J.A., Jensen L.T., Fugger L., Burdakov D. Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area. Eur J Neurosci 2012, 35:1426-1432.
54. Lemos J.C., Wanat M.J., Smith J.S., Reyes B.A., Hollon N.G., Van Bockstaele E.J., Chavkin C., Phillips P.E. Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature 2012, 490:402-406.